The global high-content screening market is expected to reach USD 909.0 Million by 2022 from USD 557.1 Million in 2017, at a CAGR of 10.3%.
Danaher Corporation holds a leading position in the market. The company designs, manufactures, and markets professional, medical, industrial, and commercial products & services. Danaher Corporation primarily focuses on product launches as its key business strategy. For example, in February 2017, Molecular Devices, LLC (U.S.), a subsidiary of Danaher Corporation, launched the SpectraMax iD3 Multi-Mode Microplate Reader. This added another platform to the company’s portfolio to expand its reach in the HCS market. In April 2016, Molecular Devices, LLC (U.S.) launched the ImageXpress Micro 4 High-content Imaging System. This further strengthened the company’s HCS product portfolio.
High-content screening (HCS) is a method that is used in biological research and drug discovery to identify substances such as small molecules, peptides, or RNAi that alter the phenotype of a cell in a desired manner. High-content screening includes any method used to analyze whole cells or components of cells with a simultaneous readout of several parameters.
Becton, Dickinson and Company (BD) is one of the major players in the market. The company has a strong presence in the HCS market due to its extensive product portfolio, ranging from instruments to accessories in flow cytometry. It operates globally through a network of offices across North America, Europe, Asia-Pacific, Eastern Europe, the Middle East, and Africa. To maintain its position in the market, the company has been focusing on technological advancements in flow cytometry. In the last three years, the company has launched several products, such as the BD FACSMelody System, BD FACSymphony, BD FACSPresto system, BD FACSCelesta system, and BD FACSVia flow cytometer.
The key strategies adopted by major players in the global high-content screening market are agreements, partnerships & collaborations, acquisitions, product launches, and geographic expansions. In this competitive market, global players aim to maintain their market position through continuous investments in R&D with a focus on developing innovative solutions or enhancing their existing solutions.
Get more Details @ https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html
The global high-content screening (HCS) market is consolidated in nature with the top five players commanding a major share of the market. GE Healthcare (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Becton, Dickinson and Company (U.S.) lead the global market. Some of the other leading players in this market include BioTek Instruments Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Tecan Group Ltd. (Switzerland), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.).
